Ophthalmology · Columbus, OH
NPI
1205812997
Since 2005
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
262 Neil Ave Ste 430
Columbus, OH, 43215
Phone (614) 221-7464
Groups this clinician bills Medicare through
Medicare paid, 2024
$149K
1,875 services
Medicare patients, 2024
680
Average age 77
Drug cost, 2024
$1.9M
1,363 prescriptions
Company payments, 2025
$107K
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Alice T Epitropoulos was code 92250 (angiography), 439 times for 424 patients. In total Alice T Epitropoulos billed 1,875 services in 30 codes, and Medicare paid $149K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-12-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92250 Angiography | Office | 439 | 424 | $23.28 | $10K |
| 99214 Office E&M - Established | Office | 317 | 263 | $82.65 | $26K |
| 92014 Ophthalmological E&M | Office | 258 | 251 | $72.76 | $19K |
| 92136 Ultrasound - Nonspecific | Office | 109 | 109 | $27.86 | $3,037 |
| 66984 Cataract Surgery | Facility | 104 | 79 | $392.56 | $41K |
| 99212 Office E&M - Established | Office | 102 | 99 | $31.72 | $3,236 |
| 92083 Vision, Hearing, and Speech Services | Office | 90 | 88 | $43.27 | $3,894 |
| 99213 Office E&M - Established | Office | 69 | 54 | $62.51 | $4,313 |
| 68841 Eye | Facility | 64 | 49 | $12.13 | $777 |
| 66821 Cataract Surgery | Office | 63 | 53 | $223.10 | $14K |
| 92285 Standard X-ray | Office | 47 | 32 | $15.02 | $706 |
| 92020 Ophthalmological E&M | Office | 39 | 38 | $17.38 | $678 |
| 99204 Office E&M - New | Office | 35 | 35 | $97.43 | $3,410 |
| 92004 Ophthalmological E&M | Office | 28 | 28 | $85.03 | $2,381 |
| 92133 Computerized Ophthalmic Imaging | Office | 21 | 21 | $24.72 | $519 |
By year: 2022 $154K for 1,974 services; 2023 $157K for 1,923 services; 2024 $149K for 1,875 services.
Medicare prescription drug claims, 2024
In 2024, the drug Alice T Epitropoulos prescribed most often to Medicare patients was Moxifloxacin (Moxifloxacin Hcl), with 230 prescriptions and refills. In total Alice T Epitropoulos wrote 1,363 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Moxifloxacin Moxifloxacin Hcl | 230 | 231 | 162 | $4,291 |
| Restasis Cyclosporine | 208 | 322 | 97 | $197K |
| Prednisolone Acetate Generic | 153 | 174 | 129 | $4,447 |
| Miebo Perfluorohexyloctane/Pf | 118 | 145 | 34 | $107K |
| Lotemax Sm Loteprednol Etabonate | 67 | 71 | 45 | $17K |
| Cyclosporine Generic | 61 | 99 | 30 | $21K |
| Vevye Cyclosporine | 55 | 70 | 17 | $50K |
| Latanoprost Generic | 55 | 108 | 18 | $718 |
| Prolensa Bromfenac Sodium | 46 | 82 | 40 | $16K |
| Tyrvaya Varenicline Tartrate | 38 | 39 | Under 11 | $22K |
| Cequa Cyclosporine | 33 | 49 | 12 | $27K |
| Xiidra Lifitegrast | 32 | 64 | 13 | $42K |
| Bepotastine Besilate Generic | 29 | 34 | 18 | $2,971 |
| Xdemvy Lotilaner | 26 | 37 | 25 | $48K |
| Oxervate Cenegermin-Bkbj | 25 | 25 | Under 11 | $1.3M |
Brand drugs: 965 claims; generic drugs: 398 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Alice T Epitropoulos $107K ($106K in general payments such as food, travel and fees and $1,167 for research) from 14 companies. The largest payer was Bausch & Lomb Americas Inc. with $59K.
| Company | Payments | Amount |
|---|---|---|
| Bausch & Lomb Americas Inc. BLCO | 54 | $59K |
| Alcon Vision LLC ALC | 17 | $28K |
| Alcon Research LLC ALC | 2 | $6,000 |
| Abbvie Inc. ABBV | 16 | $3,481 |
| Ocular Therapeutix, Inc. OCUL | 3 | $2,726 |
| Johnson & Johnson Surgical Vision, Inc. JNJ | 6 | $2,561 |
| Tarsus Pharmaceuticals, Inc. TARS | 13 | $2,401 |
| Harrow Eye, LLC | 8 | $1,830 |
| Mallinckrodt Hospital Products Inc. | 10 | $367 |
| Dompe US, Inc. | 6 | $201 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.